FANJ
INSY

Financial Architects (New Jersey)’s Insys Therapeutics, Inc. INSY Stock Holding History

Financial Architects (New Jersey)’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6
Closed – – 1579
2019
Q1 		$0 Hold
6
– – ﹤0.01% 1585
2018
Q4 		$0 Hold
6
– – ﹤0.01% 1560
2018
Q3 		$0 Hold
6
– – ﹤0.01% 1566
2018
Q2 		$0 Sell
6
-1,500
-100% -$10.5K ﹤0.01% 1584
2018
Q1 		$9K Sell
1,506
-2,045
-58% -$16.9K ﹤0.01% 1133
2017
Q4 		$34K Buy
3,551
+2,000
+129% +$13.1K 0.01% 805
2017
Q3 		$14K Hold
1,551
– – ﹤0.01% 1057
2017
Q2 		$20K Hold
1,551
– – ﹤0.01% 961
2017
Q1 		$16K Hold
1,551
– – ﹤0.01% 1009
2016
Q4 		$14K Sell
1,551
-105
-6% -$1.19K ﹤0.01% 943
2016
Q3 		$20K Buy
1,656
+1,650
+27,500% +$25.1K 0.01% 852
2016
Q2 		$0 Buy
+6
New +$87 ﹤0.01% 1506

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Financial Architects (New Jersey)'s INSY Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 6 shares.

Financial Architects (New Jersey) first reported a position in INSY in Q2 2016 and held it in 12 quarters. The position peaked at $34K in Q4 2017. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 6 Insys Therapeutics, Inc. shares in Q2 2019.
  • Financial Architects (New Jersey) first reported a position in Insys Therapeutics, Inc. in Q2 2016 and held it in 12 quarters.
  • Financial Architects (New Jersey)'s Insys Therapeutics, Inc. position peaked at $34K in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.